M13-694 (GOG3005): A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovaria

  • Levine, Lyuba, (PI)

Project: Other project

StatusFinished
Effective start/end date6/14/166/13/17

Funding

  • AbbVie Inc